Low income earners and those receiving unemployment or other government pension benefits pay a 'concessional' co-payment which is much lower than the 'general' population co-payment.
Model 4 refers to population-based payments.
This paper aims to identify the factors that impact screening for chronic diseases of lifestyle (CDL), cancers, and HIV in a health-insured population with equal payment access, some of whom are exposed to incentives for screening, specific to South Africa.
Although, the obstetricians volunteered their time, and were not paid by the project, their time was valued using average salary rates as, in the case of scale-up to a larger population, an incentive payment may be necessary.
In this health-insured population with equal payment access for screening services, significant variations exist in the utilization of preventive screening care based on gender, plan type, exposure to incentives, and provincial location.
Payments from 1995/96 – 1996/97 were used to identify chronic conditions for the 1996/97 study population, and 2004/05-2005/06 payments were used to identify chronic conditions for the 2005/06 study population.
While in Kenya upwards of 50percentt of the population uses mobile payments platforms, in Mexico the proportion is barely above 2percentt.
A Blue Cross & Blue Shield of Massachusetts contract restricts audits to 150 claims and states that any troubling trends discovered cannot be used "to calculate the financial impact of errors in a population of claim payments"–meaning, don't even think about extrapolating the cost.
Unlike trials, however, these studies can offer generalizability to diverse populations, providers, and payment models and are of particular salience to payers.
For this reason, accurate methods are needed to estimate the morbidity burdens of specific individuals and populations; otherwise, the payment may become misaligned with medical needs [ 7].
